Newsletter
Newsletter #32
Hey there! The past two weeks have been remarkably productive for new publications. Between the 2026 Surviving Sepsis Campaign guidelines and several high-impact clinical trials, there is a lot to cover. Enjoy the read! P.S. I haven’t forgotten the second part of our previous clinical case—I’ve